Type of Study: Epidemiological

Sponsor / Support: LACOG, Movember

Primary Objectives: Describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer and overall survival and identify clinical and molecular disease subtypes that predict response to individual treatments, combinations or sequences.

Sample Size: 5.000 patients

Principal Investigator: Andre Fay

Countries LATAM: Brazil